Anna Podolanczuk   Assistant Professor

Dr. Podolanczuk is an NIH-funded investigator studying novel risk factors for pulmonary fibrosis in humans. Her research program focuses on understanding early or subclinical interstitial lung disease, characterizing imaging and blood biomarkers of pulmonary fibrosis, the role of environmental exposures, and the connection between cardiovascular disease and pulmonary fibrosis.

Publications

Sort by

selected publications

Research

Sort by

Funding awarded

Background

Contact

full name

  • Anna Podolanczuk

primary email

  • ajp9012@med.cornell.edu

External Relationships

externalRelationships

  • Relationships and collaborations with for-profit and not-for-profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

    Advisory/Scientific Board Member refers to a group of individuals who have been selected to advise a business regarding any number of issues (e.g., scientific advisory board member, medical advisory board member)Advisory/Scientific Board Member:
    PureTech Health; United Therapeutics
    Consultant refers to an individual who provides expert advice to a business or entity (e.g., consulting on medical devices or pharmaceuticals)Consultant:
    Boehringer Ingelheim Pharmaceuticals, Inc. (USA); EBSCO; Eisai, Inc.; Imvaria Inc.; Pliant Therapeutics, Inc; Regeneron Pharmaceuticals, Inc.; Roche Pharmaceuticals, Inc.; Veracyte, Inc.